Page 266 - EJMO-9-2
P. 266

Eurasian Journal of
            Medicine and Oncology                                          The genetics of chronic stress in cervical lesions



               with  24-hour  urinary  catecholamines  in  individuals   interactions. Dis Model Mech. 2023;16(1):dmm049729.
               with  untreated  high  blood pressure.  Psychosom Med.      doi: 10.1242/dmm.049729
               2016;77(2):136-144.
                                                               24.  Magnon C, Hall SJ, Lin J,  et al. Autonomic nerve
               doi: 10.1097/PSY.0000000000000144                  development contributes to prostate cancer progression.
            13.  Shioda N, Imai Y, Yabuki Y, Sugimoto W, Yamaguchi K,   Science. 2013;341(6142):1236361.
               Wang Y. Dopamine D2L receptor deficiency causes stress      doi: 10.1126/science.1236361
               vulnerability through 5-HT1A receptor dysfunction in
               serotonergic neurons. J Neurosci. 2019;39(38):7551-7563.  25.  Zhao CM, Hayakawa Y, Kodama Y,  et al. Denervation
                                                                  suppresses gastric tumorigenesis.  Sci Transl Med.
               doi: 10.1523/JNEUROSCI.0079-19.2019                2014;6(250):250ra115.
            14.  Brindley RL, Bauer MB, Walker LA, et al. Adrenal serotonin      doi: 10.1126/scitranslmed.3009569
               derives from accumulation by the antidepressant-sensitive
               serotonin transporter. Pharmacol Res. 2019;140:56-66.  26.  Peterson SC, Eberl M, Vagnozzi AN,  et al. Basal cell
                                                                  carcinoma preferentially arises from stem cells within
               doi: 10.1016/j.phrs.2018.06.008                    hair follicle and mechanosensory niches.  Cell Stem Cell.
            15.  Cao Y. Tumorigenesis as a process of gradual loss of original   2015;16(4):400-412.
               cell identity and gain of properties of neural precursor/     doi: 10.1016/j.stem.2015.02.006
               progenitor cells. Cell Biosci. 2017;7(1):61.
                                                               27.  Roda N, Blandano G, Pelicci PG. Blood vessels and
               doi: 10.1186/s13578-017-0188-9                     peripheral nerves as key players in cancer progression and
            16.  Li  Y,  Yang  S,  Sadaoui  NC,  et al.  Sustained  adrenergic   therapy resistance. Cancers (Basel). 2021;13(17):4471.
               activation of YAP1 induces anoikis resistance in cervical      doi: 10.3390/cancers13174471
               cancer cells. iScience. 2020;24;23(7):101289.
                                                               28.  Silverman DA, Martinez VK, Dougherty PM, Myers JN,
               doi: 10.1016/j.isci.2020.101289                    Calin GA, Amit M. Cancer-associated neurogenesis and
            17.  Lutfy K, Aimiuwu O, Mangubat M, et al. Nicotine stimulates   nerve-cancer cross-talk. Cancer Res. 2021;81(6):1431-1440.
               secretion of corticosterone via both CRH and AVP receptors.      doi: 10.1158/0008-5472.CAN-20-2793
               J Neurochem. 2012;120(6):1108-1116.
                                                               29.  Adriaenssens E, Vanhecke E, Saule P, et al. Nerve growth
               doi: 10.1111/j.1471-4159.2011.07633.x              factor is a potential therapeutic target in breast cancer.
            18.  Weisstaub NV, Zhou M, Lira A,  et al. Cortical 5-HT2A   Cancer Res. 2008;68(2):346-351.
               receptor signaling modulates anxiety-like behaviors in mice.      doi: 10.1158/0008-5472.CAN-07-1183
               Science. 2006;313(5786):536-540.
                                                               30.  Watanabe T, Katayama Y, Kimura S, Yoshino A. Control
               doi: 10.1126/science.1123432                       of proliferation and survival of C6 glioma cells with
            19.  Boilly B, Faulkner S, Jobling P, Hondermarck H. Nerve   modification of the nerve growth factor autocrine system.
               dependence: From regeneration to cancer.  Cancer Cell.   J Neurooncol. 1999;41(2):121-128.
               2017;31(3):342-354.                                doi: 10.1023/a:1006127624487
               doi: 10.1016/j.ccell.2017.02.005                31.  Demir IE, Tieftrunk E, Schorn S, Friess H, Ceyhan GO.
            20.  Mancino M, Ametller E, Gascón P, Almendro V. The   Nerve growth factor & TrkA as novel therapeutic targets in
               neuronal influence on tumor progression Biochim Biophys.   cancer. Biochim Biophys Acta. 2016;1866(1):37-50.
               2011;1816(2):105-118.                              doi: 10.1016/j.bbcan.2016.05.003
               doi: 10.1016/j.bbcan.2011.04.005                32.  Bapat AA, Munoz RM, Von Hoff DD, Han H. Blocking nerve
            21.  Benzaquen D, Lawrence YR, Taussky D, Zwahlen D,   growth factor signaling reduces the neural invasion potential
               Oehler C, Champion A. The crosstalk between nerves   of pancreatic cancer cells. PLoS One. 2016;11(10):e0165586.
               and cancer-a poorly understood phenomenon and new      doi: 10.1371/journal.pone.0165586
               possibilities. Cancers (Basel). 2024;6(10):1875.
                                                               33.  Lei Y, Tang L, Xie Y, et al. Gold nanoclusters-assisted delivery
               doi: 10.3390/cancers16101875                       of NGF siRNA for effective treatment of pancreatic cancer.
            22.  Bernstock JD, Gerstl JVE, Chen JA,  et al. The case for   Nat Commun. 2017;8:15130.
               neurosurgical intervention in cancer neuroscience.      doi: 10.1038/ncomms15130
               Neurosurgery. 2025;96(1):10-17.
                                                               34.  Brodeur GM. Neuroblastoma: Biological insights into a
               doi: 10.1227/neu.0000000000003039                  clinical enigma. Nat Rev Cancer. 2003;3(3):203-216.
            23.  Le TT, Oudin MJ. Understanding and modeling nerve-cancer      doi: 10.1038/nrc1014


            Volume 9 Issue 2 (2025)                        258                         doi: 10.36922/EJMO025100047
   261   262   263   264   265   266   267   268   269   270   271